Revaly
Revaly helps subscription and recurring-revenue businesses stop losing money to failed transactions by transforming payment systems into revenue engines. Its AI-driven payment intelligence evaluates issuer signals and network behavior in real time to keep legitimate payments from failing. Instead of letting small errors or timing issues derail a customer’s purchase, Revaly corrects problems proactively before the user hits “pay.” When a payment does decline, the platform automatically determines the best moment and method to retry, using behavioral science to protect customer trust. Companies using Revaly see major increases in recovered revenue, improved profitability, and significantly reduced involuntary churn. The platform integrates with more than 100 billing, CRM, and payment tools, eliminating the need for operational changes. Performance metrics across retail, software, and media industries consistently show double-digit recovery improvements. Ultimately, Revaly gives businesses a predictable, scalable way to grow by ensuring their earned revenue successfully processes.
Learn more
Checksum.ai
Engineering teams shipping with AI have a new bottleneck: validation. Code output has accelerated. Quality hasn't. Checksum closes the gap.
Checksum is a continuous quality platform with a suite of AI agents that handle testing end-to-end, at every stage of the development lifecycle. Where most tools wait for a human to trigger them, Checksum runs autonomously in the background, generating tests, executing them, and repairing failures without manual intervention. Seventy percent of test failures are resolved automatically through real-time auto-recovery.
The platform covers every layer: end-to-end UI flows via Playwright, API endpoint chains, and targeted CI tests scoped to exactly what changed in a PR. All tests land as real code in your repository and are delivered as standard Playwright, owned by your team.
Checksum is fine-tuned on 1.5+ million test runs and integrates natively with Cursor, Claude Code, and 100+ AI coding agents. Type /checksum and your coding agent's output gets tested before it ever reaches review. Generation and healing happen on Checksum's cloud infrastructure which means no LLM tokens consumed, no local resources required.
The result: test suites that stay green as the product evolves, fewer regressions reaching production, and release confidence that scales alongside AI output.
Learn more
Us2.ai
Us2.ai is revolutionizing the battle against heart disease by utilizing AI-driven ultrasound software that ensures heart health can be accessible to everyone. This innovative platform provides 45 automated echo parameters, such as strain analysis, and enables real-time interpretation of 2D and Doppler images. It seamlessly integrates with any ultrasound machine, producing zero-click, comprehensive reports that maintain high accuracy and can be easily compared with expert evaluations. The AI echo copilot from Us2.ai autonomously analyzes all heart chambers through both 2D and Doppler perspectives, incorporating global reference guidelines into detailed, real-time reports. Recently, the software obtained FDA clearance for Us2.v2, which also boasts 45 automated echo parameters, including strain analysis, representing a remarkable advancement in healthcare technology. Ultimately, Us2.ai aims to democratize echocardiography, ensuring that ultrasound technology is available to individuals regardless of their location or circumstances, thereby promoting better heart health for all. This commitment to accessibility and innovation positions Us2.ai at the forefront of the medical technology landscape.
Learn more
Merlin CardioMotion
Merlin's CardioMotionTM echo analysis and reporting software, distributed by CDN in Australia, revolutionizes support for swiftly identifying cardiac problems. Designed for use in emergency medicine, CCU/ICU settings, oncology departments, medical center clinicians, ultrasound facilities, cardiology units, and even in regional or remote locations that rely on point-of-care devices, it also proves advantageous for cardiac monitoring during clinical trials. What sets Merlin CardioMotionTM apart is its ability to process slow frame rate echo clips accurately without needing an ECG trace for detection, making it compatible with lower-specification ultrasound machines. Employing groundbreaking image processing technology, it is built upon a foundation of proprietary algorithms that facilitate the automatic identification of the ventricular wall and its borders. This innovative approach allows for a swift and precise quantitative evaluation of the heart's dynamic functioning, ultimately enhancing patient care. With its capabilities, healthcare providers can make informed decisions and improve outcomes in cardiac health management.
Learn more